Neil P Shah1. Show Affiliations » 1. Department of Hematology/Oncology, University of California-San Francisco, San Francisco, California, USA.
Abstract
Entities: Chemical Disease Mutation
Mesh： See more » Antineoplastic Agents/administration & dosageAntineoplastic Agents/therapeutic useBiomedical ResearchClinical Trials, Phase I as TopicFusion Proteins, bcr-abl/antagonists & inhibitorsFusion Proteins, bcr-abl/geneticsHumansImidazoles/administration & dosageImidazoles/therapeutic useLeukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapyLeukemia, Myelogenous, Chronic, BCR-ABL Positive/geneticsMolecular Targeted TherapyMutationPyridazines/administration & dosagePyridazines/therapeutic use
Substances： See more » Antineoplastic AgentsImidazolesPyridazinesponatinibFusion Proteins, bcr-abl
Year: 2011 PMID： 22252660
Source DB: PubMed Journal: Clin Adv Hematol Oncol ISSN： 1543-0790